A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Trial details
- Registry ID
- NCT04762069
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Berubicin Hydrochloride
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeNCT04762069 | CNSP | Phase 2 | Active not recruiting | 2026-04-27Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |